A quantitative evaluation of the neurospasmolytic effect of orphenadrine by direct and telemedographed electromyography.
D004558:Electric Stimulation; D004576:Electromyography; D006699:Home Care Services; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009132:Muscles / Q000627:therapeutic use*; D009966:Orphenadrine / Q000627:therapeutic use*; D010044:Outpatient Clinics, Hospital; D013686:Telemetry; D014202:Tremor / Q000188:drug therapy
D009966:Orphenadrine